Randomized, double-Blind, placebo-controlled trial of cimicifuga racemosa (Black Cohosh) in women with anxiety disorder due to menopause

Journal of Clinical Psychopharmacology

Volumn 29, Issue 5, 2009, Pages 478-483

  Amsterdam, Jay D ^a   Yao, Yubing ^b   Mao, Jun James ^c   Soeller, Irene ^a   Rockwell, Kenneth ^c   Shults, Justine ^b  

^a The Science Center Philadelphia   (United States)

^b Center for Clinical Epidemiology and Biostatistics

^c UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Anxiety disorder; Black cohosh; Cimicifuga racemosa; Complementary and alternative medicine; Menopause; Perimenopause

Indexed keywords

CIMICIFUGA RACEMOSA EXTRACT; PLACEBO;

ABDOMINAL CRAMP; ANXIETY; ANXIETY DISORDER; ARTHRALGIA; ARTICLE; BLOATING; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIAPHORESIS; DIARRHEA; DIZZINESS; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; DRUG WITHDRAWAL; EDEMA; FEMALE; HAMILTON ANXIETY SCALE; HUMAN; MENOPAUSE; PAIN; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SIDE EFFECT; SLEEP DISORDER; TRANQUILIZING ACTIVITY; TREATMENT OUTCOME; VAGINA BLEEDING; XEROSTOMIA;

AGED; ANXIETY DISORDERS; CIMICIFUGA; DOUBLE-BLIND METHOD; FEMALE; HUMANS; MENOPAUSE; MIDDLE AGED; PHYTOTHERAPY; PLANT EXTRACTS; VASOMOTOR SYSTEM;

EID: 70349661392     PISSN: 02710749     EISSN: None     Source Type: Journal    
DOI: 10.1097/JCP.0b013e3181b2abf2     Document Type: Article

References (41)

1. Kronenberg F. Hot flashes: epidemiology and physiology. Ann N Y Acad Sci. 1990;592:52-86.
2. Bair YA, Gold EB, Azari RA, et al. Use of conventional and complementary health care during the transition to menopause: longitudinal results from the study of women's health across the nation (SWAN). Menopause. 2005;12:31-39.
3. Umland EM. Treatment strategies for reducing the burden of menopause-associated vasomotor symptoms. J Manag Care Pharm. 2008;14:14-19.
4. Maoz B, Shiber A, Lazer S, et al. Prevalence of psychological distress among postmenopausal women attending a menopausal clinic and the effect of hormone replacement therapy on their mental state. Menopause. 1994;1:137-141.
5. Maartens LW, Leusink GL, Knottnerus JA, et al. Climacteric complaints in the community. Fam Pract. 2001;18:189-194.
6. Byrne P. Psychiatric morbidity in a gynecology clinicVan epidemiological survey. Br J Psychiatry. 1981;144:28-34.
7. Hay AG, Bancroft J, Johnstone EC. Affective symptoms in women attending a menopause clinic. Br J Psychiatry. 1994;164:513-516.
8. Conboy L, Domer A, O'Connell E. Women at mid-life: symptoms, attitudes, and choices, an internet-based survey. Maturitas. 2001; 38:129-136.
9. Wiklund I, Karlberg J, Mattsson LA. Quality of life of postmenopausal women on a regimen of transdermal estradiol therapy: a double-blind placebo-controlled study. Am J Obstet Gynecol. 1993;168:824-830.
10. Bukulmez O, Al A, Gurdal H, et al. Short-term effects of three continuous hormone replacement therapy regimens on platelet tritiated imipramine binding and mood scores: a prospective randomized trial. Fertil Steril. 2001;75:737-743.
11. Rickels K, Moller H-J. Anxiety: new treatment perspectives. J Clin Psychiatry. 2002;63:3.
12. Davidson J, Bose A, Korotzer A, et al. Escitalopram in the treatment of generalized anxiety disorder: double-blind, placebo-controlled, flexible dose study. Depress Anxiety. 2004;19:234-240.
13. O'Connor K, Belanger L, Marchand A, et al. Psychological distress and adaptational problems associated with discontinuation of benzodiazepines. Addict Behav. 1999;24:537-541.
14. Amsterdam JD, Garcia-Espana F, Goodman D, et al. Breast enlargement during chronic SSRI therapy. J Affect Disord. 1997;46:151-156.
15. Rossouw JE, Anderson GL, Prentice RL, et al. Risks and benefits of estrogen plus progestin in healthy postmenopausal womenVprincipal results from the Women's Health Initiative randomized controlled trial. JAMA. 2002;288:321-333.
16. Tindle HA, Davis RB, Phillips RS, et al. Trends in use of complementary and alternative medicine by US adults: 1997-2002. Altern Ther Health Med. 2005;11:42-49.
17. Stratton TD, McGivern-Snofsky JL. Toward a sociological understanding of complementary and alternative medicine use. J Altern Complement Med. 2008;14:777-783.
18. Jacobson JS, Troxel AB, Evans J, et al. Randomized trial of black cohosh for the treatment of hot flashes among women with a history of breast cancer. J Clin Oncol. 2001;19:2739-2745.
19. Nappi RE, Malavasi B, Brundu B, et al. Efficacy of Cimicifuga racemosa on climacteric complaints: a randomized study versus low-dose transdermal estradiol. Gynecol Endocrinol. 2005;20:30-35.
20. Briese V, Stammwitz U, Friede M, et al. Black cohosh with or without St. John's wort for symptom-specific climacteric treatmentVresults of a large-scale, controlled, observational study. Maturitas. 2007;57:405-414.
21. Frei-Kleiner S, Schaffner W, Rahlfs VW, et al. Cimicifuga racemosa dried ethanolic extract in menopausal disorders: a double-blind placebo-controlled clinical trial. Maturitas. 2005;51:397-404.
22. Newton KM, Reed SD, LaCroix AZ, et al. Treatment of vasomotor symptoms of menopause with black cohosh, multibotanicals, soy, hormone therapy, or placebo: a randomized trial. Ann Intern Med. 2006;145:869-879.
23. Pockaj BA, Gallagher JG, Loprinzi CL, et al. Phase III double-blind, randomized, placebo-controlled crossover trial of black cohosh in the management of hot flashes: NCCTG Trial N01CC1. J Clin Oncol. 2006;20:2836-3284
24. Burdette JE, Liu J, Chen SN, et al. Black cohosh acts as a mixed competitive ligand and partial agonist of the serotonin receptor. J Agric Food Chem. 2003;51:5661-5670.
25. Rebbeck TR, Troxel AB, Norman S, et al. A retrospective case-control study of the use of hormone-related supplements and association with breast cancer. Int J Cancer. 2007;120:1523-1528.
26. First MB, Spitzer RL, Gibbon M, et al. Structured Clinical Interview for DSM-IV-TR Axis I Disorders, Research Version, Patient Edition With Psychotic Screen (SCID-I/P W/ PSY SCREEN). New York, NY: Biometrics Research, New York State Psychiatric Institute; 2002.
27. Hamilton M. The assessment of anxiety status by rating. Br J Med Psychol. 1959;32:50-55.
28. Beck AT, Epstein N, Brown G, et al. An inventory for measuring clinical anxiety: psychometric properties. J Consult Clin Psychol. 1988;56: 893-897.
29. Greene JG. Constructing a standard climacteric scale. Maturitas. 1998;29:25-31.
30. Grossi E, Groth N, Mosconi P, et al. Development and validation of the short version of the Psychological General Well-Being Index (PGWB-S). Health Qual Life Outcomes. 2006;4:88.
31. National Institute of Mental Health. Treatment Emergent Symptoms Scale (TESS). Psychopharmacol Bull. 1985;21:1069-1073.
32. Li W, Chen S, Fabricant S, et al. High-performance liquid chromatographic analysis of black cohosh (Cimicifuga racemosa) constituents with in-line evaporative light scattering and photodiode array detection. Anal Chim Acta. 2002;471:61-75.
33. Shults J, Ratcliffe SJ, Leonard M. Improved generalized estimating equation analysis via xtqls for quasi-least squares in Stata. Stata J. 2007;7:147-166.
34. Mao JJ, Farrar JT, Xie SX, et al. Use of complementary and alternative medicine and prayer among a national sample of cancer survivors compared to other populations without cancer. Complement Ther Med. 2007;15:21-29.
35. Pagan JA, Pauly MV. Access to conventional medical care and the use of complementary and alternative medicine. Health Aff (Millwood). 2005;24:255-262.
36. Givens JL, HoustonTK,VanVoorheesBW, et al. Ethnicity and preferences for depression treatment. Gen Hosp Psychiatry. 2007;29:182-191.
37. Givens JL, Katz IR, Bellamy S, et al. Stigma and the acceptability of depression treatments among African Americans and whites. J Gen Intern Med. 2007;22:1292-1297.
38. Stoll W. Phytopharmacon influences atrophic vaginal epithelium: double-blind study of Cimicifuga vs estrogenic substances [in German]. Therapeutikon. 1987;1:1-14.
39. Morelli V, Naquin C. Alternative therapies for traditional disease states: menopause. Am Fam Physician. 2002;66:129-134.
40. Osmers R, Friede M, Liske E, et al. Efficacy and safety of isopropanolic black cohosh extract for climacteric symptoms. Obstet Gynecol. 2005;105:1074-1083.
41. Oktem M, Eroglu D, Karahan HB, et al. Black cohosh and fluoxetine in the treatment of postmenopausal symptoms: a prospective, randomized trial. Adv Ther. 2007;24:448-461.